| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |